All In Biotech

Free tool

FAERS Monitor: Flagyl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020334 or its brand name (Flagyl, Metronidazole). Reports on generic versions are filed under their own applications.

Reports

63,834

Serious

53,748

84% of reports

Hospitalization

27,270

Death reported

6,909

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5,512
  • nausea4,677
  • off label use4,209
  • diarrhoea4,084
  • vomiting3,308
  • pyrexia3,224
  • drug hypersensitivity3,164
  • pain3,035
  • abdominal pain3,004
  • headache2,880
  • fatigue2,803
  • dyspnoea2,244
  • dizziness2,182
  • condition aggravated2,166
  • malaise2,000

Reports by year received

View as table
YearReports
2004768
2005819
2006874
2007887
2008767
20091,179
20101,432
20111,903
20122,383
20132,164
20142,426
20153,273
20163,757
20173,481
20185,261
20195,610
20204,735
20214,501
20223,972
20233,936
20243,586
20253,743
20262,373

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,990,325 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal3,1645.55.311,439
abdominal painSignal3,0044.34.17,583
pyrexiaSignal3,2243.13.04,587
condition aggravatedSignal2,1662.42.31,704
vomitingSignal3,3082.32.32,543
diarrhoeaSignal4,0842.12.02,384
nausea4,6772.01.92,245
pain3,0351.61.6759
off label use4,2091.61.5947
headache2,8801.51.5518
malaise2,0001.51.4344
dizziness2,1821.41.4303
drug ineffective5,5121.41.3611
dyspnoea2,2441.31.3166
fatigue2,8031.21.185

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.